Shuye Wang

818 total citations
30 papers, 440 citations indexed

About

Shuye Wang is a scholar working on Molecular Biology, Hematology and Spectroscopy. According to data from OpenAlex, Shuye Wang has authored 30 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Spectroscopy. Recurrent topics in Shuye Wang's work include Innovative Microfluidic and Catalytic Techniques Innovation (6 papers), Acute Myeloid Leukemia Research (6 papers) and Analytical Chemistry and Chromatography (6 papers). Shuye Wang is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (6 papers), Acute Myeloid Leukemia Research (6 papers) and Analytical Chemistry and Chromatography (6 papers). Shuye Wang collaborates with scholars based in China, United States and Canada. Shuye Wang's co-authors include Jian Tang, Weihua Tang, Yun Dai, Jie Zhou, Xiaoxia Li, Jinxiao Hou, Shengjin Fan, Jin Zhou, Limin Li and Xueying Han and has published in prestigious journals such as Blood, Cancer and Journal of Chromatography A.

In The Last Decade

Shuye Wang

30 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuye Wang China 13 227 132 108 100 62 30 440
Girija Ramaswamy India 12 147 0.6× 22 0.2× 14 0.1× 17 0.2× 70 1.1× 22 338
Fumiya Ito Japan 14 347 1.5× 80 0.6× 50 0.5× 26 0.3× 70 1.1× 25 749
Irene Neudorfer Germany 10 118 0.5× 43 0.3× 98 0.9× 41 0.4× 21 0.3× 15 482
Kenneth Lau United States 10 289 1.3× 53 0.4× 95 0.9× 56 0.6× 34 0.5× 13 482
Oriana Marques Germany 12 150 0.7× 243 1.8× 41 0.4× 7 0.1× 77 1.2× 28 574
Alberto Santagostino Italy 9 227 1.0× 193 1.5× 16 0.1× 39 0.4× 100 1.6× 17 473
Go Urabe United States 14 355 1.6× 17 0.1× 23 0.2× 99 1.0× 47 0.8× 29 558
David Schuller United States 11 237 1.0× 26 0.2× 118 1.1× 9 0.1× 234 3.8× 19 630
Subramanian Yegneswaran United States 15 223 1.0× 417 3.2× 22 0.2× 8 0.1× 23 0.4× 27 696
H.Ş. Çoşkun Türkiye 6 95 0.4× 123 0.9× 19 0.2× 8 0.1× 96 1.5× 11 497

Countries citing papers authored by Shuye Wang

Since Specialization
Citations

This map shows the geographic impact of Shuye Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuye Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuye Wang more than expected).

Fields of papers citing papers by Shuye Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuye Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuye Wang. The network helps show where Shuye Wang may publish in the future.

Co-authorship network of co-authors of Shuye Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuye Wang. A scholar is included among the top collaborators of Shuye Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuye Wang. Shuye Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Min, Jing-Ming Guo, Yuping Gong, et al.. (2024). Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study. The Lancet Regional Health - Western Pacific. 47. 101096–101096. 1 indexed citations
2.
Lian, Xin, et al.. (2023). WWP2 binds to NKRF, enhances the NF-κB signaling, and promotes malignant phenotypes of acute myeloid leukemia cells. Biochemistry and Cell Biology. 102(1). 85–95. 1 indexed citations
3.
Qiao, Song, et al.. (2023). Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies. Frontiers in Medicine. 10. 1167759–1167759. 1 indexed citations
4.
Jing, Haijiao, Xiaoming Wu, Mengqi Xiang, et al.. (2022). The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment. Frontiers in Cardiovascular Medicine. 9. 957006–957006. 7 indexed citations
5.
Zhang, Wei, Liping Su, Lihong Liu, et al.. (2021). The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study. Cancer Biology and Medicine. 18(3). 841–848. 22 indexed citations
6.
Su, Wenjia, Xingjian Niu, Hongfei Ji, et al.. (2020). A novel classification based on B-cell receptor signal gene expression correlates with prognosis in primary breast diffuse large B-cell lymphoma. Journal of Cancer. 11(9). 2431–2441. 4 indexed citations
7.
Zhang, Lulu, et al.. (2020). Sodium orthovanadate inhibits growth of acute leukemia HL60 cells and HL60/A cells in vitro. Bioscience Reports. 40(9). 3 indexed citations
10.
Hou, Jinxiao, Shuye Wang, Yingmei Zhang, et al.. (2017). Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide. Annals of Hematology. 96(12). 2005–2013. 16 indexed citations
11.
Zhang, Gong, Wenjun Wang, Shuping Zhang, et al.. (2017). Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma. Oncotarget. 8(43). 74661–74672. 25 indexed citations
12.
Ge, Fei, Yingmei Zhang, Fenglin Cao, et al.. (2016). Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia – A retrospective clinical study. Hematology. 21(5). 287–294. 10 indexed citations
13.
Wang, Yongzhe, et al.. (2015). Magnetic Resonance Imaging Features of Schwannoma of the Sinonasal Tract. Journal of Computer Assisted Tomography. 39(6). 860–865. 12 indexed citations
14.
Wang, Shuye, et al.. (2014). Leukaemia cutis as the initial manifestation in a child with brachydactyly in chronic phase of chronic myeloid leukaemia. Pathology. 46(6). 569–570. 1 indexed citations
15.
Wang, Shuye, Yuanyuan Chen, & Zhanhe Wu. (2014). Advances in the medical research and clinical applications on the plasma DNA.. PubMed. 3(2). 140–8. 4 indexed citations
16.
Chen, Yuanyuan, Shuye Wang, & Wei Wang. (2013). Deletion of chromosome 17 as a novel cytogenetic finding in chronic neutrophilic leukemia: A case report. Oncology Letters. 5(5). 1704–1706. 1 indexed citations
17.
Zhang, Yingmei, Zhuo Zhang, Jinmei Li, et al.. (2012). Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Cancer. 119(1). 115–125. 32 indexed citations
18.
Dai, Yun, Shuye Wang, Jie Zhou, et al.. (2012). Cationic cyclodextrin as versatile chiral selector for enantiomeric separation in capillary electrophoresis. Journal of Chromatography A. 1246. 98–102. 40 indexed citations
19.
Wang, Shuye, Yun Dai, Jian Wu, et al.. (2012). Methoxyethylammonium monosubstituted β-cyclodextrin as the chiral selector for enantioseparation in capillary electrophoresis. Journal of Chromatography A. 1277. 84–92. 26 indexed citations
20.
Li, Huibo, Fenglin Cao, Yanhua Su, et al.. (2010). Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. Thrombosis and Haemostasis. 104(12). 1235–1241. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026